Clinical Trial Details
| Trial ID: | L7055 |
| Source ID: | NCT06402747 |
| Associated Drug: | Clopidogrel |
| Title: | Clopidogrel Versus Cilostazol on Vessels |
| Acronym: | |
| Status: | RECRUITING |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes|Atherosclerosis |
| Interventions: | DRUG: Clopidogrel|DRUG: Cilostazol |
| Outcome Measures: | Primary: Changes of carotid intima-media thickness, mm, 52 weeks | Secondary: Changes of circulation, measured by ankle brachial index and laser doppler, 52 weeks|Changes of HbA1c, 26 and 52 weeks|Changes of glucose, mg/dL, 26 and 52 weeks|Changes of body weight, kg, 26 and 52 weeks|Changes of whole body fat, measured by bioelectrical impedance analysis, 26 and 52 weeks|Changes of blood pressures, systolic, diastolic (mmHg), 26 and 52 weeks|Changes of lipids, total cholesterol, triglycerides, LDLc, HDLc (mg/dL), 26 and 52 weeks|Changes of peripheral pain or ischemic symptoms, measured by questionnaires (visual analogue scale: 100), 26 and 52 weeks|Changes of laboratory values related to blood clot, prothrombin time, activated partial thromboplastin time, 26 and 52 weeks |
| Sponsor/Collaborators: | Sponsor: Seoul National University Bundang Hospital | Collaborators: Samjin Pharmaceutical Co., Ltd. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 120 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION |
| Start Date: | 2024-04-16 |
| Completion Date: | 2027-12-31 |
| Results First Posted: | |
| Last Update Posted: | 2024-05-07 |
| Locations: | Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT06402747 |
